A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

E Kneppers; H Lokhorst; C Eeltink; G Huls; S Wittebol; MJ Kersten; RA Raymakers; M Schaafsma; P Sonneveld; E Vellenga; P Wijermans; S Zweegman

Journal Article

A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

Kneppers E
Lokhorst H
Eeltink C
et al.

Clinical Lymphoma and Myeloma (2009) 9 S47-S48

DOI: 10.1016/s1557-9190(11)70531-5

N/ACitations

N/AReaders

Get full text

Cite

CITATION STYLE

APA

Kneppers, E., Lokhorst, H., Eeltink, C., Huls, G., Wittebol, S., Kersten, M., … Zweegman, S. (2009). A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients. Clinical Lymphoma and Myeloma, 9, S47–S48. https://doi.org/10.1016/s1557-9190(11)70531-5

A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

Cite

Register to see more suggestions